Keywords: متروکسی پروژسترون استات; Differential scanning calorimetry; Electron paramagnetic resonance; Fluorescence anisotropy; Fourier transform infrared spectroscopy; Human steroid hormones; Membrane; ANS; 1-anilino-8-naphthalene sulfonate; 12-AS; 12-(9-antroiloxy)-stearic acid; BDP; bec
مقالات ISI متروکسی پروژسترون استات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: متروکسی پروژسترون استات; AF; activation functions; BZA; bazedoxifene; CE; conjugated estrogens; E2; 17β-estradiol; E3; estriol; E4; estetrol; EDC; estrogen dendrimer conjugate; EE; ethinylestradiol; EMA; European Medicines Agency; ER; estrogen receptor; FDA; Food and Drug Admini
Interaction of glucocorticoids and progesterone derivatives with human serum albumin
Keywords: متروکسی پروژسترون استات; Bil; Bilirubin; Co; cortisol; Cn; cortisone; DYG; dydrogesterone; 9-FA; 9-fluorocortisol acetate; FTIR; Fourier Transform Infrared Spectroscopy; GC; glucocorticoid; HSA; Human Serum Albumin; 17-OHPG; 17-hydroxyprogesterone; 21-OHPG; 21-hydroxyprogesterone
Keywords: متروکسی پروژسترون استات; Canine; Uterus; Medroxyprogesterone acetate; Progestin; Morphometry; MPA; Acetate of Medroxyprogesterone; FSH; Follicle-stimulating hormone; LH; Luteinizing hormone; VV; density volume; SV; Surface density; SD; standard deviation;
Keywords: متروکسی پروژسترون استات; Estrogen; Neuroprotection; Aging; Cognition; Stroke; Traumatic brain injury; 3NPA; 3-nitropropionic acid; 17αE2; 17 alpha-estradiol; 17βE2; 17 beta-estradiol; ATP; adenosine triphosphate; BBB; blood brain barrier; BDNF; brain-derived neurotrophic factor
Keywords: متروکسی پروژسترون استات; 8-OHdG; 8-hydroxy-2' -deoxyguanosine; ASCUS; atypical squamous cells of uncertain significance; BV; bacterial vaginosis; CST; community state type; HNCF; human normal fibroblast-like cervical; HPV; human papillomavirus; HSIL; high-grade squamous intraepit
Keywords: متروکسی پروژسترون استات; Self-administration; Medroxyprogesterone acetate; Injections; Contraception; Uniject; Patient education;
Keywords: متروکسی پروژسترون استات; CBT; cognitive behavioral therapy; CYP2D6; cytochrome P450 2D6; DHEA; dehydroepiandrosterone; FDA; Food and Drug Administration; GSM; genitourinary syndrome of menopause; MPA; medroxyprogesterone acetate; SERM; selective estrogen receptor modulator; SGB;
Keywords: متروکسی پروژسترون استات; SLE; systemic lupus erythematosus; HT; hormone therapy; VTE; venous thromboembolism; DHEA; didehydroepiandrosterone; SLE-DAI; systemic lupus erythematous disease activity index; SELENA; Safety of Estrogens in Lupus Erythematosus National Assessment; CEE;
Keywords: متروکسی پروژسترون استات; AD; Alzheimer's disease; ANOVA; analysis of variance; CEE; conjugated equine estrogen; DG; dydrogesterone; E2; 17β-estrogen; HRT; Hormone Replacement Therapy; MPA; medroxyprogesterone acetate; MWM; Morris water maze; OFT; open field test; OVX; ovariect
Keywords: متروکسی پروژسترون استات; Medroxyprogesterone acetate; Breast cancer; Androgen receptor; Cardiovascular disease; Neuroprotection;
Keywords: متروکسی پروژسترون استات; Tamoxifen; Mania; Treatment; Bipolar disorder; Schizoaffective disorder; Medroxyprogesterone acetate;
Keywords: متروکسی پروژسترون استات; endometrial cancer; levonorgestrel-intrauterine system (LNG-IUS); medroxyprogesterone acetate; progesterone;
Keywords: متروکسی پروژسترون استات; Medroxyprogesterone acetate; Growth factors; Breast cancer cells; Progesterone receptor membrane component-1; Proliferation;
Keywords: متروکسی پروژسترون استات; VVA; vulvovaginal atrophy; SERM; selective estrogen receptor modulator; NDA; new drug application; FDA; Food and Drug Administration; NSABP; National Surgical Adjuvant Breast & Bowel Project; STAR; Study of Tamoxifen and Raloxifene; ER; estrogen receptor;
Keywords: متروکسی پروژسترون استات; SPs; synthetic progestins; MPA; medroxyprogesterone acetate; MGA; megestrol acetate; CLA; chlormadinone acetate; NET; norethisterone; NED; norethynodrel; LNG; levonorgestrel; PR; progesterone receptor; mA; monomer A; mB; monomer B; EB; estradiol benzoate;
Medroxyprogesterone acetate drives M2 macrophage differentiation toward a phenotype of decidual macrophage
Keywords: متروکسی پروژسترون استات; Medroxyprogesterone acetate; Macrophage; Differentiation;
In an in-vitro model using human fetal membranes, 17-α hydroxyprogesterone caproate is not an optimal progestogen for inhibition of fetal membrane weakening
Keywords: متروکسی پروژسترون استات; 17-alpha hydroxyprogesterone caproate; biomechanical weakening; fetal membranes; granulocyte-macrophage colony-stimulating factor; medroxyprogesterone acetate; preterm premature rupture of the fetal membranes; progesterone; progestogens; thrombin; tumor
Novel anti-inflammatory liposomal formulation for the pre-ocular tear film: In vitro and ex vivo functionality studies in corneal epithelial cells
Keywords: متروکسی پروژسترون استات; Corneal epithelial cells; Drug delivery; Glucocorticoid receptor; Inflammation; Liposome; Progesterone receptor; BAC; benzalkonium chloride; C6; coumarin-6; DED; dry eye disease; DMEM/F12; Dulbecco's Modified Eagle Medium + F12 medium mixture; EE; encap
Effects of chemotherapy agents on Sphingosine-1-Phosphate receptors expression in MCF-7 mammary cancer cells
Keywords: متروکسی پروژسترون استات; Sphingosine-1-phosphate; Tamoxifen; Medroxyprogesterone acetate; Mammary cancer; Autophagy
Effect of PFOS on glucocorticoid-induced changes in human decidual stromal cells in the first trimester of pregnancy
Keywords: متروکسی پروژسترون استات; PFOS; perfluorooctane sulfonate; 11β-HSD1; 11β -hydroxysteroid dehydrogenase 1; PFCs; perfluorinated compounds; cAMP; 8-bromo-cAMP; MPA; medroxyprogesterone acetate; PRL; prolactin; IGFBP; insulin growth factor binding protein 1; qRT-PCR; quantitative r
Activity of binary mixtures of drospirenone with progesterone and 17α-ethinylestradiol in vitro and in vivo
Keywords: متروکسی پروژسترون استات; DRS; drospirenone; P4; progesterone; MPA; medroxyprogesterone acetate; DDG; dydrogesterone; CA; concentration addition; AR; androgen receptor; ER; estrogen receptor; PR; progesterone receptor; MR; mineralocorticoid receptor; hpf; hours post fertilization;
Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5α-dihydroprogesterone (5αP) and can be suppressed by the 5α-reductase inhibitor, finasteride
Keywords: متروکسی پروژسترون استات; 5αP; 5α-dihydroprogesterone; ELISA; enzyme-linked immunosorbent assay; ER; estrogen receptor; MAPK; mitogen-activated protein kinase; MPA; medroxyprogesterone acetate; P; progesterone; PR; progesterone receptor; RIA; radioimmunoassay; Breast cancer inhi
17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review
Keywords: متروکسی پروژسترون استات; Bioidentical hormones; 17β-Estradiol; Menopause; Progesterone; Vasomotor symptoms; CBHT; compounded bioidentical hormone therapy; CEE; conjugated equine estrogens; EMA; European Medicines Agency; FDA; Food and Drug Administration; HDL-C; high-density lip
Progesterone inhibits in vitro fetal membrane weakening
Keywords: متروکسی پروژسترون استات; fetal membrane; GM-CSF; medroxyprogesterone acetate; PPROM; progesterone; thrombin; TNF; weakening;
Reprint of “Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: Is it safe?”
Keywords: متروکسی پروژسترون استات; Medroxyprogesterone acetate; Breast cancer; Androgen receptor; Cardiovascular disease; Neuroprotection
Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization
Keywords: متروکسی پروژسترون استات; Medroxyprogesterone acetate; controlled ovarian stimulation; premature LH surge;
A Randomized Crossover Study of Medroxyprogesterone Acetate and Diane-35 in Adolescent Girls with Polycystic Ovarian Syndrome
Keywords: متروکسی پروژسترون استات; Polycystic ovarian syndrome; Adolescents; Medroxyprogesterone acetate; Cyproterone acetate; Quality of life
Pharmacologic Treatment of Paraphilias
Keywords: متروکسی پروژسترون استات; Sex offender; Paraphilia; Pedophilia; Selective serotonin reuptake inhibitor; Medroxyprogesterone acetate; Gonadotropin-releasing hormone analogue; Cyproterone acetate;
Female mice with deletion of Type One 5α-reductase have reduced reproductive responding during proestrus and after hormone-priming
Keywords: متروکسی پروژسترون استات; Allopregnanolone; Medroxyprogesterone acetate; Sexual behavior; Midbrain; Lordosis
Molecular and structural basis of androgen receptor responses to dihydrotestosterone, medroxyprogesterone acetate and Î4-tibolone
Keywords: متروکسی پروژسترون استات; Androgen receptor; Progestins; Medroxyprogesterone acetate; Testosterone; Coactivators; Molecular models;
A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A)
Keywords: متروکسی پروژسترون استات; Prog; progesterone; AR; androgen receptor; HT; hormone therapy; MPA; medroxyprogesterone acetate; NET; norethisterone; NET-A; norethisterone acetate; NET-EN; norethisterone enanthate; DHT5; α-dihydrotestosterone; MIB; mibolerone; RU486; mifepristone; THG
Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy
Keywords: متروکسی پروژسترون استات; Prog; progesterone; MR; mineralocorticoid receptor; HRT; hormone replacement therapy; MPA; medroxyprogesterone acetate; NET; norethisterone; NET-A; norethisterone acetate; NET-EN; norethisterone enanthate; Ald; aldosterone; MRE/GRE; mineralocorticoid/gluc
Depot Medroxyprogesterone Acetate Use Is Not Associated With Risk of Incident Sexually Transmitted Infections Among Adolescent Women
Keywords: متروکسی پروژسترون استات; Adolescent; Medroxyprogesterone acetate; Prospective studies; Sexual behavior; Sexually transmitted diseases;
Progesterone-induced neuroprotection: Factors that may predict therapeutic efficacy
Keywords: متروکسی پروژسترون استات; Progesterone; Medroxyprogesterone acetate; Neuroprotection; Therapeutic window
Phase behavior of carbon dioxide + medroxyprogesterone acetate system at high pressures
Keywords: متروکسی پروژسترون استات; Phase equilibrium; Medroxyprogesterone acetate; CO2; Supercritical; Equation of state
FT-IR study on interactions between medroxyprogesterone acetate and solvent in CHCl3/cyclo-C6H12 and CCl4/cyclo-C6H12 binary solvent systems
Keywords: متروکسی پروژسترون استات; Solvent effect; Medroxyprogesterone acetate; Hydrogen bonding; Interaction;
Membrane bioreactor for the treatment of pharmaceutical wastewater containing corticosteroids
Keywords: متروکسی پروژسترون استات; Membrane bioreactor; Pharmaceutical wastewater; Corticosteroids; Medroxyprogesterone acetate
Glycosaminoglycan profiles in the uterus of adult ovariectomized rats treated with estrogen and progestagen
Keywords: متروکسی پروژسترون استات; Estrogens; Conjugated (USP); Glycosaminoglycans; Medroxyprogesterone acetate; Rats; Uterus;
Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels
Keywords: متروکسی پروژسترون استات; Levonorgestrel-releasing intrauterine system; Medroxyprogesterone acetate; Menorrhagia; Hemoglobin; Ferritin
Expression of human aldo-keto reductase 1C2 in cell lines of peritoneal endometriosis: Potential implications in metabolism of progesterone and dydrogesterone and inhibition by progestins
Keywords: متروکسی پروژسترون استات; 5α-DHT, 5α-dihydrotestosterone; 5α-DHP, 5α-dihydroprogesteroneProgesterone metabolism; Dydrogesterone; Progesterone; 20α-Hydroxysteroid dehydrogenase; 20α-Dihydrodydrogesterone; Medroxyprogesterone acetate
The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives
Keywords: متروکسی پروژسترون استات; emergency contraception; etonogestrel; levonorgestrel; medroxyprogesterone acetate; norethindrone
Differential effects of estrogen and micronized progesterone or medroxyprogesterone acetate on cognition in postmenopausal women
Keywords: متروکسی پروژسترون استات; Postmenopause; micronized progesterone; medroxyprogesterone acetate; estrogen; cognition; mood;
Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg)
Keywords: متروکسی پروژسترون استات; Pharmacokinetics; Pharmacodynamics; Medroxyprogesterone acetate; Estradiol Cypionate; Intramuscular and subcutaneous
Development and evaluation of matrix type transdermal patch of ethinylestradiol and medroxyprogesterone acetate for anti-implantation activity in female Wistar rats
Keywords: متروکسی پروژسترون استات; Transdermal; Interception; Postcoital antifertility; Ethinylestradiol; Medroxyprogesterone acetate
QSAR classification models for the prediction of endocrine disrupting activity of brominated flame retardants
Keywords: متروکسی پروژسترون استات; ED; endocrine disrupting; REACH; Registration, Evaluation, Authorization and Restriction of Chemicals; QSAR; quantitative structure-activity relationship; OECD; Organization for Economic Cooperation and Development; BFRs; brominated flame retardants; T4
Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3
Keywords: متروکسی پروژسترون استات; Dydrogesterone; 20α-Hydroxydydrogesterone; Progesterone; Medroxyprogesterone acetate; 20α-Hydroxyprogesterone; Aldo-keto reductase
Bioidentical Hormone Therapy
Keywords: متروکسی پروژسترون استات; BHT; bioidentical HT; bi-est; bi-estrogen; CBHT; compounded bioidentical HT; CEE; conjugated equine estrogen; E+P; estrogen plus progestin; FDA; US Food and Drug Administration; HT; hormone therapy; MPA; medroxyprogesterone acetate; tri-est; tri-estrogen;
Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells
Keywords: متروکسی پروژسترون استات; Metformin; Medroxyprogesterone acetate; Endometrial cancer; Progesterone receptor; AMPK; Mammalian target of rapamycin
Estrogen induces neurite outgrowth via Rho family GTPases in neuroblastoma cells
Keywords: متروکسی پروژسترون استات; Estrogen; Medroxyprogesterone acetate; Neurite outgrowth; Rac1; Cdc42;